Stroke remains a significant cause of morbidity and mortality worldwide. Early recognition and swift intervention are crucial in mitigating the devastating consequences of this medical emergency. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Early stroke recognition is vital for prompt intervention. The BE FAST model is an effective tool for identifying potential stroke patients. B for Balance difficulties, E for Eyesight problems, F for Face drooping, A for Arm weakness, S for Speech difficulties, and T for Time to call emergency services. This model emphasizes the importance of swift action in the face of potential stroke symptoms.
Once a stroke is suspected, immediate management includes maintaining airway, breathing, and circulation, stabilizing vital signs, and initiating intravenous access. It is also crucial to obtain a rapid brain imaging study, preferably a non-contrast CT scan, to differentiate between ischemic and hemorrhagic stroke.
Acute ischemic stroke management may involve intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) if administered within 4.5 hours of symptom onset. Endovascular procedures like mechanical thrombectomy can be considered within 24 hours in certain patients. Hemorrhagic stroke management focuses on controlling blood pressure, reversing anticoagulation, and surgical intervention when indicated.
Stroke recognition and management require a systematic approach. Utilizing the BE FAST model can facilitate early identification of symptoms. Immediate stabilization, appropriate imaging, and timely intervention can significantly improve patient outcomes. As healthcare professionals, staying abreast of the latest guidelines and advancements in stroke care is paramount.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation